Brainstorm Cell Therapeutics Inc. (BCLI) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Brainstorm Cell Therapeutics Inc. Company Snapshot

Business Description:

Brainstorm Cell Therapeutics Inc. operates in the Biological products exc. diagnostic sector. BrainStorm Cell Therapeutics Inc. (BrainStorm) is a clinical-stage biotechnological company developing noncontroversial, adult stem cell therapeutic products, derived from autologous (self) bone marrow cells, for the treatment of chronic, life threatening neurodegenerative disorders. The company's primary targets are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) and Parkinson's disease (PD). These diseases have limited treatment options and as such represent unmet medical needs. Upon completion of BrainStorm's clinical trials program and regulatory approvals, this stem cell therapy focuses to provide medical and economic benefits for patients, medical practitioners, and insurance/healthcare providers. The Company holds rights to develop and commercialize the technology through worldwide licensing agreement with Ramot, the technology transfer company of the Tel-Aviv University.

Stock Performance Chart for Brainstorm Cell Therapeutics Inc.

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): .23
(Figures in U.S. Dollars)

1 Week	3.6%	13 Weeks	-4.2%

4 Weeks	-14.8%	52 Weeks	0.0%

Brainstorm Cell Therapeutics Inc. Key Data:

Ticker:	BCLI	Country:	UNITED STATES

Exchanges:	OTC	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Medical, Surgical & Dental Suppliers

2003 Sales	82,889 (Year Ending Jan 2004).	Employees:	10

Currency:	U.S. Dollars	Market Cap:	28,915,441

Fiscal Yr Ends:	December	Shares Outstanding:	125,719,309

Share Type:	Common	Closely Held Shares:	63,094,939

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.